Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Pinnaql has completed the acquisition of Pharma Resource Group, a healthcare services other business in New York. Pinnaql acquisitions focus on expanding healthcare services capabilities, and the Pharma Resource Group acquisition adds operational support for healthcare customers across NY. The add on acquisition strengthens Pinnaql’s healthcare M&A footprint through a private equity acquisition strategy targeting service delivery and client engagement. The announced add on acquisition is described as a tuck-in, marking another Pinnaql acquisitions effort backed by Boomerang, with deal size undisclosed and terms not publicly detailed.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Volaris Group→Interplayers
Apr 30, 2026
Tenet Healthcare→United Surgical Partners International
Apr 30, 2026